A client taking riociguat for pulmonary arterial hypertension has a new vericiguat prescription after a heart-failure hospitalization. Which action should the nurse take?
1Give both drugs and obtain orthostatic vital signs after the first combined dose.
2Hold vericiguat and ask the prescriber to resolve the duplicate sGC-stimulator regimen.✓ Correct answer
3Stop riociguat and substitute vericiguat at the next routine medication time.
4Delay vericiguat until systolic pressure rises, then administer both as prescribed.
Explanation
Vericiguat is contraindicated with another soluble guanylate cyclase stimulator such as riociguat because the combination can produce excessive hypotension.
Quick answer Do not combine vericiguat with riociguat.
Why this is correct Both drugs stimulate soluble guanylate cyclase. The nurse holds the new medication and resolves the interacting regimen rather than independently discontinuing chronic therapy.
Easy analogy or mental picture Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.
Memory hook Drug, urgent cue, protective action, and reassessment endpoint.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: VERQUVO (vericiguat)Contraindication with other soluble guanylate cyclase stimulators and hypotension-related interaction safety
Medication-safety reviewVerify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.